Phase I multiple-dose trial of FX 125L in healthy subjects.
Phase of Trial: Phase I
Latest Information Update: 11 Jan 2010
At a glance
- Drugs FX 125L (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease; Inflammatory bowel diseases; Psoriasis; Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Funxional Therapeutics
- 11 Jan 2010 Status changed from not stated to completed.
- 11 Jan 2010 New trial record